<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">51662</article-id><article-id pub-id-type="doi">10.7554/eLife.51662</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-119458"><name><surname>Oh</surname><given-names>Hyung Suk</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1739-0389</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-160168"><name><surname>Neuhausser</surname><given-names>Werner M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5092-2658</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-160169"><name><surname>Eggan</surname><given-names>Pierce</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160170"><name><surname>Angelova</surname><given-names>Magdalena</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-160356"><name><surname>Kirchner</surname><given-names>Rory</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80544"><name><surname>Eggan</surname><given-names>Kevin C</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" corresp="yes" id="author-41802"><name><surname>Knipe</surname><given-names>David M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1554-6236</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf6"/></contrib><aff id="aff1"><institution content-type="dept">Department of Microbiology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Obstetrics and Gynecology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Stem Cell and Regenerative Biology</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Biostatistics</institution>, <institution>Harvard T H Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-43030"><name><surname>Sawyer</surname><given-names>Sara L</given-names></name><role>Reviewing editor</role><aff><institution>University of Colorado Boulder</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>wneuhaus@bidmc.harvard.edu</email> (WN);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>david_knipe@hms.harvard.edu</email> (DK);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>12</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e51662</elocation-id><history><date date-type="received"><day>06</day><month>09</month><year>2019</year></date><date date-type="accepted"><day>01</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Oh et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Oh et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-51662-v1.pdf"/><abstract><p>Herpes simplex virus (HSV) establishes lifelong latent infection and can cause serious human disease, but current antiviral therapies target lytic but not latent infection. We screened for sgRNAs that cleave HSV-1 DNA sequences efficiently <italic>in vitro</italic> and used these sgRNAs to observe the first editing of quiescent HSV-1 DNA. The sgRNAs targeted lytic replicating viral DNA genomes more efficiently than quiescent genomes, consistent with the open structure of lytic chromatin. Editing of latent genomes caused short indels while editing of replicating genomes produced indels, linear molecules and large genomic sequence loss around the gRNA target site. The HSV ICP0 protein and viral DNA replication increased the loss of DNA sequences around the gRNA target site. We conclude that HSV, by promoting open chromatin needed for viral gene expression and by inhibiting the DNA damage response, makes the genome vulnerable to a novel form of editing by CRISPR-Cas9 during lytic replication.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P01 AI098681</award-id><principal-award-recipient><name><surname>Knipe</surname><given-names>David M</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R21 AI135423</award-id><principal-award-recipient><name><surname>Eggan</surname><given-names>Kevin C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Hyung Suk Oh, We have patent applications pending. U.S. Patent application No. 62/365,826, International Patent Application PCT/US2017/043225.</p></fn><fn fn-type="conflict" id="conf3"><p>Werner M Neuhausser, We have patent applications pending. U.S. Patent application No. 62/365,826, International Patent Application PCT/US2017/043225.</p></fn><fn fn-type="conflict" id="conf4"><p>Magdalena Angelova, We have patent applications pending. U.S. Patent application No. 62/365,826, International Patent Application PCT/US2017/043225.</p></fn><fn fn-type="conflict" id="conf5"><p>Kevin C Eggan, We have patent applications pending. U.S. Patent application No. 62/365,826, International Patent Application PCT/US2017/043225.</p></fn><fn fn-type="conflict" id="conf6"><p>David M Knipe, Reviewing editor, <italic>eLife</italic>We have patent applications pending. U.S. Patent application No. 62/365,826, International Patent Application PCT/US2017/043225.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Colgrove RC</collab><collab>Liu X</collab><collab>Griffiths A</collab><collab>Raja P</collab><collab>Deluca NA</collab><collab>Newman RM</collab><collab>Coen DM</collab><collab>Knipe DM</collab></person-group><year iso-8601-date="2015">2015</year><source>Human herpesvirus 1 isolate KOS, complete genome</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KT899744">https://www.ncbi.nlm.nih.gov/nuccore/KT899744</ext-link><comment>NCBI GenBank: KT899744.1</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Miga KH</collab><collab>Newton Y</collab><collab>Jain M</collab><collab>Altemose N</collab><collab>Willard HF</collab><collab>Kent WJ</collab></person-group><year iso-8601-date="2014">2014</year><source>hg38</source><ext-link ext-link-type="uri" xlink:href="https://genome.ucsc.edu/cgi-bin/hgGateway?db=hg38">https://genome.ucsc.edu/cgi-bin/hgGateway?db=hg38</ext-link><comment>Genome Reference Consortium, Human GRCh38.p12 (GCA_000001405.27)</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-51662-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>